Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 5Ovarian Neoplasms 2Colorectal Neoplasms 2Tuberous Sclerosis 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Pediatric Solid Tumor 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms 1Lymphangioleiomyomatosis 1Histiocytosis, Non-Langerhans-Cell 1Histiocytosis, Langerhans-Cell 1HER2-positive Breast Cancer 1Early Detection of Cancer 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Castleman Disease 1Breast Screening 1Breast Neoplasms, Male 1Brain Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Genetic Testing 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Castleman Disease × Genetic Testing × 90 days × Clear all
NCT05028621 2026-05-07

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Case Comprehensive Cancer Center

Phase NA Suspended
135 enrolled
LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡